Drug Profile
Hair follicle-derived stem cell therapeutics - AntiCancer
Alternative Names: DermaTek; Hair follicle pluripotent stem cells; hfPS; Lipo-4MALatest Information Update: 28 May 2020
Price :
$50
*
At a glance
- Originator AntiCancer
- Class Gene therapies; Pluripotent stem cell therapies
- Mechanism of Action Cholestenone 5-alpha reductase inhibitors; Stem cell growth factor agonists; Stem cell modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Acne; Alopecia; Cardiovascular disorders; Neurological disorders
Most Recent Events
- 28 May 2020 No recent reports of development identified for research development in Cardiovascular-disorders in USA (Parenteral)
- 16 Jul 2016 No recent reports of development identified for preclinical development in Acne in USA (Topical)
- 16 Jul 2016 No recent reports of development identified for preclinical development in Alopecia(Chemotherapy-induced) in USA (Topical)